Zynfuse
Engineered Rigid Fixation and Advanced Osteosynthesis Technology Supporting CCSS Networks, Private Surgical Hubs, and Thoracic Centers across Central America.
Direct access to clinical-grade systems optimized for immediate surgical intervention and trauma support.
Aligning with local regulatory authorities, CCSS supply workflows, and the private medical hub network.
Costa Rica has rapidly transitioned into the primary cardiovascular and medical manufacturing gateway of Central America. Led by the centralized public health administrator, the Caja Costarricense de Seguro Social (CCSS), alongside internationally accredited private networks such as Hospital CIMA, Hospital Metropolitano, and Clínica Bíblica, the demand for highly reliable implants has scaled. For cardiosurgical and thoracic clinics across San José, Alajuela, and Cartago, postoperative outcomes rely directly on the structural reliability of bone closure systems.
As a major exporter to Latin American corridors, Zynfuse Medical recognizes the rigorous requirements set by Costa Rica's health regulator, the Ministerio de Salud de Costa Rica (deSalud). Importation of Class III implantable devices demands extensive evidence of biocompatibility, mechanical endurance, and traceable production records. Zynfuse supports local distributors and hospital purchasing boards with comprehensive validation documentation, including ISO 13485 declarations and raw material testing records.
We provide full logistical and certification support to facilitate straightforward tenders via Costa Rica's electronic procurement platform, SICOP.
Our raw materials comply strictly with ASTM F136 standards for surgical titanium, ensuring low hypersensitivity and fast osseointegration.
Fast ocean and air shipping channels into San José's primary logistics hubs, complete with customs-ready medical documentation.
A critical comparison of rigid internal plate stabilization versus traditional monofilament wire cerclage.
Median sternotomy remains the standard surgical exposure method for complex open-heart procedures, including coronary artery bypass grafting (CABG), aortic valve replacements, and congenital defect repairs. Traditionally, stainless steel wire cerclage was the primary closure standard. However, clinical studies indicate that wire closure is highly susceptible to cutting through osteoporotic bone, causing construct instability, high postoperative pain, and potentially life-threatening complications such as deep sternal wound infection (DSWI) or mediastinitis.
Zynfuse’s Sternal Fixation System offers a superior engineering solution based on the mechanical principles of rigid internal fixation. Utilizing low-profile titanium alloy plates (Ti-6Al-4V ELI) that contour to the sternum's unique anatomy, our system distributes physiological respiratory stresses evenly across the bone surface. This prevents micro-motion, maintains primary anatomical reduction, and dramatically shortens patient recovery times.
Equipped with 18,600m² of advanced cleanrooms and production capacity, exporting to over 1,200 partners globally.
Founded in 2016, Zynfuse Medical Technology Co., Ltd. is a professional orthopedic medical device manufacturer specializing in advanced bone fusion and implant systems. Backed by 12 years of industry experience and 7 years of specialized medical export capability, Zynfuse has established a highly efficient global supply network serving markets across North America, Europe, the Middle East, and Latin America.
Our ISO 13485-certified facility utilizes cutting-edge Swiss-type CNC lathes, wire-cutting machines, and advanced metallographic analysis to ensure every implant conforms to rigorous clinical expectations. From raw titanium ingot verification to dimensional checks and packaging inside controlled cleanrooms, Zynfuse maintains a zero-defect policy.
Every step of our process, from raw material validation to final sterilization testing, undergoes rigorous inspections.























Empowering local medical professionals with customized implants and comprehensive trauma instrumentation sets.
The operating environment of a modern cardiosurgical unit in San José demands surgical tools that allow surgeons to operate efficiently. Standardized configurations do not always suit variations in patient size and bone mineral density. Zynfuse provides customizable configurations for our Sternal Fixation systems to meet these requirements.
Our implants are used in a variety of clinical scenarios, including:
To ensure clinical success, Zynfuse distributes corresponding instrument sets featuring user-friendly screw insertion guides, quick-locking drivers, and plate-bending templates. This specialized tooling simplifies adaptation to anatomical curves, minimizing tissue trauma and operating room time.
Developing the next generation of smart biocompatible implants and patient-specific stabilization solutions.
Zynfuse’s dedicated R&D department, consisting of over 85 engineers, continuously evaluates emerging clinical trends to drive design enhancements. We are focusing research efforts on three key areas to improve outcomes in thoracic reconstruction:
Researching magnesium-based and bioabsorbable copolymer plates that provide stable fixation during bone healing and gradually dissolve, eliminating permanent foreign materials.
Developing CAD-to-implant workflows using SLM 3D printing to create patient-specific thoracic reconstruction plates for complex tumors and trauma reconstructions.
Integrating micro-electronic telemetry sensors that monitor real-time mechanical strain and detect early micro-movements, warning clinicians of potential healing issues.
Essential compliance, logistical, and technical insights for healthcare buyers and distributors in Costa Rica.
Zynfuse manufacturing operates strictly under an ISO 13485 quality system. Our products are accompanied by extensive mechanical testing reports (tensile strength, fatigue properties) and raw material certificates (ASTM F136 surgical titanium) to support registration with the Ministerio de Salud de Costa Rica.
For standard specifications, Zynfuse maintains a continuous inventory, allowing dispatch from our warehouse within 7–15 working days. Tailored OEM/ODM designs or high-volume hospital orders typically require 30–45 days for precision manufacturing and sterilization testing.
Yes, our R&D engineering team of 85 specialists provides complete custom manufacturing (OEM/ODM). We can modify plate dimensions, thickness, profile shapes, and screw lock configurations to match specific surgical requirements or local market needs.
Yes, we provide specialized orthopedic instrument sets designed specifically for our plating lines. We also support distributors with technical documentation and video guides for sterilizing and using the implants and instruments.
Explore our broader selection of ISO 13485 certified bone fixation implants and surgical systems.
Request physical product samples, compliance documentation, or localized pricing packages tailored for public hospital tenders and private medical networks in Costa Rica.